These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 26645411)
1. Allosteric Modulators: A Side Door. Abood ME J Med Chem; 2016 Jan; 59(1):42-3. PubMed ID: 26645411 [TBL] [Abstract][Full Text] [Related]
2. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe. Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127 [TBL] [Abstract][Full Text] [Related]
3. Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery. Gado F; Meini S; Bertini S; Digiacomo M; Macchia M; Manera C Future Med Chem; 2019 Aug; 11(15):2019-2037. PubMed ID: 31517528 [TBL] [Abstract][Full Text] [Related]
4. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity. Dopart R; Lu D; Lichtman AH; Kendall DA Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030 [TBL] [Abstract][Full Text] [Related]
5. Diarylureas Containing 5-Membered Heterocycles as CB Nguyen T; Gamage TF; Decker AM; German N; Langston TL; Farquhar CE; Kenakin TP; Wiley JL; Thomas BF; Zhang Y ACS Chem Neurosci; 2019 Jan; 10(1):518-527. PubMed ID: 30188693 [TBL] [Abstract][Full Text] [Related]
8. In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor. Sabatucci A; Tortolani D; Dainese E; Maccarrone M Biotechnol Appl Biochem; 2018 Jan; 65(1):21-28. PubMed ID: 28833445 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators. Nguyen T; German N; Decker AM; Li JX; Wiley JL; Thomas BF; Kenakin TP; Zhang Y Bioorg Med Chem; 2015 May; 23(9):2195-2203. PubMed ID: 25797163 [TBL] [Abstract][Full Text] [Related]
10. Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1). German N; Decker AM; Gilmour BP; Gay EA; Wiley JL; Thomas BF; Zhang Y J Med Chem; 2014 Sep; 57(18):7758-69. PubMed ID: 25162172 [TBL] [Abstract][Full Text] [Related]
11. Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities. Khurana L; Mackie K; Piomelli D; Kendall DA Neuropharmacology; 2017 Sep; 124():3-12. PubMed ID: 28527758 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor. Qiao CJ; Ali HI; Ahn KH; Kolluru S; Kendall DA; Lu D Eur J Med Chem; 2016 Oct; 121():517-529. PubMed ID: 27318976 [TBL] [Abstract][Full Text] [Related]
13. Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor. Nguyen T; Li JX; Thomas BF; Wiley JL; Kenakin TP; Zhang Y Med Res Rev; 2017 May; 37(3):441-474. PubMed ID: 27879006 [TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications. Kulkarni AR; Garai S; Janero DR; Thakur GA Methods Enzymol; 2017; 593():281-315. PubMed ID: 28750808 [TBL] [Abstract][Full Text] [Related]
15. Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators. Garai S; Kulkarni PM; Schaffer PC; Leo LM; Brandt AL; Zagzoog A; Black T; Lin X; Hurst DP; Janero DR; Abood ME; Zimmowitch A; Straiker A; Pertwee RG; Kelly M; Szczesniak AM; Denovan-Wright EM; Mackie K; Hohmann AG; Reggio PH; Laprairie RB; Thakur GA J Med Chem; 2020 Jan; 63(2):542-568. PubMed ID: 31756109 [TBL] [Abstract][Full Text] [Related]
16. Tuning the endocannabinoid system: allosteric modulators of the CB1 receptor. Ross RA Br J Pharmacol; 2007 Nov; 152(5):565-6. PubMed ID: 17592508 [TBL] [Abstract][Full Text] [Related]
17. Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubility. Schaffer PC; Kulkarni PM; Janero DR; Thakur GA Bioorg Med Chem; 2020 Nov; 28(21):115727. PubMed ID: 33065437 [TBL] [Abstract][Full Text] [Related]
18. Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor. Bertini S; Chicca A; Gado F; Arena C; Nieri D; Digiacomo M; Saccomanni G; Zhao P; Abood ME; Macchia M; Gertsch J; Manera C Bioorg Med Chem; 2017 Dec; 25(24):6427-6434. PubMed ID: 29079014 [TBL] [Abstract][Full Text] [Related]
19. Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors. Shang Y; Yeatman HR; Provasi D; Alt A; Christopoulos A; Canals M; Filizola M ACS Chem Biol; 2016 May; 11(5):1220-9. PubMed ID: 26841170 [TBL] [Abstract][Full Text] [Related]
20. Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy. Garai S; Leo LM; Szczesniak AM; Hurst DP; Schaffer PC; Zagzoog A; Black T; Deschamps JR; Miess E; Schulz S; Janero DR; Straiker A; Pertwee RG; Abood ME; Kelly MEM; Reggio PH; Laprairie RB; Thakur GA J Med Chem; 2021 Jun; 64(12):8104-8126. PubMed ID: 33826336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]